[1]Dellinger RP,Levy MM,Carlet JM,et al. Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008. Intensive Care Med, 2008,34(1):17-60. [2]中华医学会呼吸病学分会. 社区获得性肺炎诊断和治疗指南. 中华结核和呼吸杂志, 2006,29(10):651-655. [3]Bone RC, Balk RA,Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest,1992,101(6):1644-1655. [4]Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Confe-rence. Crit Care Med,2003, 31(4):1250-1256. [5]浙江省早期规范化液体复苏治疗协作组.危重病严重脓毒症/脓毒性休克患者早期规范化液体复苏治疗-多中心、前瞻性,随机、对照研究.中国危重病急救医学,2010,22(6):331-334. [6]Nguyen HB, Rivers EP,Knoblich BP,et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med, 2004, 32(8):1637-1642. [7]孙铁英,刘兵,扬敏. 社区获得性肺炎老年住院患者的临床分析.中华老年医学杂志, 2005,24(2):100-102. [8]朱迎钢,瞿介明. 老年人重症肺炎的难点和临床对策. 中华老年医学杂志,2008,27(1):1-4. [9]Kang CI, Kim SH, Kim HB, et al. Pseudomonas aeruglnosa bacteremia:risk factors for mortality and influence of delayed receipt of effective antimcrobial therapy on clinical outcome. Clin Infect Dis, 2003, 37(6):745-751. [10]Martin GS, Mannino DM, Eaton S, et al. The epidemiology of sepsis in the United States from 1979 through 2000.N Engl J Med, 2003,348(16):1546-1554. [11]Gaieski DF, Mikkelsen ME, Band RA, et al. Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med,2010,38(4):1045-1053. [12]朱英, 黄淮, 周琪. 急诊病房患者脓毒症患病现状及病原菌分析. 中华急诊医学杂志, 2007, 16(7):745-748. [13]Brunkhorst FM, Oppert M, Marx G, et al. Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis:a randomized trial. JAMA, 2012, 307(22):2390-2399. |